menu
    • menu

    Company profile for ReCor Medical

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ReCor Medical is a medical device company that designs and manufactures the Paradise® System, a proprietary ultrasound ablation system for renal denervation (RDN). RDN is a new potential therapeutic approach for the treatment of hypertension, one of the most prevalent medical conditions. The System’s intravascular catheters denervate renal nerves by combining the protection of water-based cooling of the renal artery with h...
    ReCor Medical is a medical device company that designs and manufactures the Paradise® System, a proprietary ultrasound ablation system for renal denervation (RDN). RDN is a new potential therapeutic approach for the treatment of hypertension, one of the most prevalent medical conditions. The System’s intravascular catheters denervate renal nerves by combining the protection of water-based cooling of the renal artery with high intensity ultrasound energy for circumferential renal nerve ablation. The Paradise System has been studied in clinical trials of approximately 300 patients to date.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ReCor MedicalUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1049 Elwell Court Palo Alto, CA 94303
    Telephone
    Telephone
    +1 650 542 7700
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.recormedical.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/recor-medical/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Otsuka Paradise Renal Denervation System Now Covered in Japan
    Otsuka Paradise Renal Denervation System Now Covered in Japan

    02 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-02/otsuka-medical-devicesotsuka-pharmaceutical-paradise-ultrasound-renal-denervation-system-for-the-t

    PHARMIWEB
    02 Mar 2026
    Share Share
    New Blood Pressure Guidelines Include Renal Denervation
    New Blood Pressure Guidelines Include Renal Denervation

    18 Aug 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/new-blood-pressure-treatment-guidelines-add-recommendations-renal-denervation

    FIERCE BIOTECH
    18 Aug 2025
    Share Share
    CMS to pay for renal denervation from Medtronic, Recor Medical
    CMS to pay for renal denervation from Medtronic, Recor Medical

    06 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/medtech/cms-hands-medicare-coverage-renal-denervation-systems-medtronic-recor-medical

    FIERCE BIOTECH
    06 Nov 2024
    Share Share
    ReCor Responds to ESH Guidelines for Management of Arterial Hypertension
    ReCor Responds to ESH Guidelines for Management of Arterial Hypertension

    14 Jul 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230714018793/en

    BUSINESSWIRE
    14 Jul 2023
    Share Share
    ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension
    ReCor Medical Announces Two Concurrent JAMA Network Publications of Study Results on the Paradise Ultrasound Renal Denervation System for the Treatment of Hypertension

    28 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230228005665/en

    BUSINESSWIRE
    28 Feb 2023
    Share Share
    Otsuka Medical Devices and ReCor Medical Announce Submission of Application for Pre-Market Approval of the Paradise™ Ultrasound Renal Denervation (uRDN) System to the U.S. Food and Drug Administration
    Otsuka Medical Devices and ReCor Medical Announce Submission of Application for Pre-Market Approval of the Paradise™ Ultrasound Renal Denervation (uRDN) System to the U.S. Food and Drug Administration

    30 Nov 2022

    // PRESS RELEASE

    https://www.omd.otsuka.com/en/information/pdf/20221130_PMA_EN.pdf

    PRESS RELEASE
    30 Nov 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search